New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 11, 2014
08:02 EDTCSIICardiovascular Systems enrolls first patient in COAST study
Cardiovascular Systems announced that the first patient has been enrolled in its Coronary Orbital Atherectomy System Trial, or COAST, trial. Taking place in the United States and Japan, the study is designed to assess the safety and efficacy, as well as economic outcomes, of CSI’s new micro crown Orbital Atherectomy System in treating severely calcified coronary lesions in patients suffering from Coronary Artery Disease. Dr. Arthur Lee, North Florida Regional Medical Center, Gainesville, Fla., performed the first procedure. Building on CSI’s ORBIT II study, the first study designed to enroll severely calcified lesions that are typically excluded from all major trials but commonly seen in the real world cases, COAST is a prospective, single-arm, multi-center, global, investigational study designed to evaluate the safety and efficacy of CSI’s new micro crown OAS in these difficult to treat lesions.
News For CSII From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 25, 2014
10:04 EDTCSIICardiovascular Systems management to meet with Benchmark
Subscribe for More Information
September 17, 2014
17:02 EDTCSIICardiovascular Systems' chairman of the board Glen Nelson retiring in November
Cardiovascular Systems' chairman of the board, Glen D. Nelson, M.D., 77, plans to retire and will not stand for re-election at the company’s annual meeting of shareholders on November 12. The board named Dr. Nelson chairman emeritus, an honorary title. Scott R. Ward, a CSI director since 2013, will be named chairman. Ward is a managing director at SightLine Partners, LLC.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use